<DOC>
	<DOCNO>NCT03049085</DOCNO>
	<brief_summary>Effect Preoperative Aspirin patient undergo Off-pump Coronary Artery Bypass Grafting . A double-blind , placebo-controlled , randomized trial .</brief_summary>
	<brief_title>Effect Preoperative Aspirin Patients Undergoing Off-pump Coronary Artery Bypass Grafting</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Eligible patient undergo offpump coronary artery bypass grafting ( OPCAB ) Patients antiplatelet therapy stop 57 day prior OPCAB Patients undergoing onpump coronary artery bypass graft Patients antiplatelet therapy stop 57 day prior OPCAB Intraoperative conversion onpump coronary artery bypass graft Patients inherited bloodclotting disorder Patients undergoing cardiac operation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>OPCAB</keyword>
	<keyword>ASA</keyword>
	<keyword>Aspirin</keyword>
</DOC>